Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / Israel

European Research Council grant · Finished

LF-LB Deep Label-Free Cell Imaging of Liquid Biopsies for Cancer Monitoring

Coordinator
Tel Aviv University, Israel
Runs
1 January 2023 to 31 December 2024
Status
Finished
EU funding
€150k
Total cost
—
Partners
1 organisations in 1 countries
Type
European Research Council grant
Grant agreement
101100664

What the project is doing

In the project's own words, from its summary on CORDIS.

We will develop and commercialize an innovative device for diagnosis and monitoring of cancer in liquid biopsies based on a label-free interferometric phase microscopy (IPM) unit, coupled with dedicated real-time artificial intelligence (AI) for cell classification. This device will materialize an innovative approach for the much-anticipated imaging flow cytometry, dramatically decreasing its costs, and improving patient care by accurate monitoring of cancer in the clinical lab from a simple lab test (liquid biopsy).

The success of the project is dependent on four high-risk/high-gain aspects: (a) Building the first clinical IPM device. (b) Designing and manufacturing a disposable microfluidic device for imaging flow cytometry. (c) Obtaining high-enough acquisition and processing throughput in imaging flow cytometry of urine samples. (d) Training a deep natural network to detect cancer cells based on the information-deep label-free IPM images of cancer cells during flow.

The proposed PoC project stems from my on-going ERC StG project that focuses on the application of IPM for grading the metastatic potential of cancer cells, as a basic-science research tool.

Topics

Who is involved

OrganisationCityCountryRole
Tel Aviv UniversityTel AvivIsraelCoordinator

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI